Načítá se...
Treatment options in non-muscle-invasive bladder cancer after BCG failure
Bladder cancer is the ninth-most prevalent cancer worldwide. Most patients with urothelial cell carcinoma of the bladder present with non-muscle-invasive disease and are treated with bacillus Calmette-Guérin (BCG) intravesical therapy. Many of these patients experience disease recurrence after BCG f...
Uloženo v:
| Vydáno v: | Indian J Urol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4626915/ https://ncbi.nlm.nih.gov/pubmed/26604442 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-1591.166475 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|